ESC Premium Access

Residual platelet reactivity after pre-treatment with ticagrelor prior to primary percutaneous coronary intervention is associated with suboptimal myocardial reperfusion

Congress Presentation

About the speaker

Professor Farzin Beygui

University Hospital of Caen, Caen (France)
5 presentations
0 follower

5 more presentations in this session

Predictive value of platelet reactivity, neutrophil to lymphocyte ratio, and hs-CRP at presentation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention

Speaker: Doctor K. Adatia (Cambridge, GB)


Is there evidence of a rebound increase in platelet aggregation following withdrawal of Aspirin or Ticagrelor in patients who have previously undergone PCI and coronary stenting?

Speaker: Doctor B. Hennigan (Cork, IE)


Effect of exercise stress test on platelet function in patients with recent acute myocardial infarction

Speaker: Doctor T. Dalcoquio (Sao Paulo, BR)


Comparative efficacy of intracoronary agents for acute treatment of coronary no-reflow: a network meta-analysis

Speaker: Associate Professor G. Klappacher (Vienna, AT)


Late mortality after pharmaco-invasive PCI for STEMI

Speaker: Professor J. French (Sydney, AU)


Access the full session

Pharmaco intervention and mechanisms in acute coronary syndromes

Speakers: Professor F. Beygui, Doctor K. Adatia, Doctor B. Hennigan, Doctor T. Dalcoquio, Associate Professor G. Klappacher...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb